Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices

Farmaco

Volumn 60, Issue 11-12, 2005, Pages 925-930

  Azarmi, Shirzad ^a   Ghaffari, Fatemeh ^a   Löbenberg, Raimar ^b   Nokhodchi, Ali ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Faculty of Pharmacy and Pharmaceutical Sciences   (Canada)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Acrylic polymers; Eudragit; Heat treating; Indomethacin; Sustained release; Thermal treating

Indexed keywords

EUDRAGIT RS; INDOMETACIN; POLYACRYLIC ACID;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; HEAT; INFRARED SPECTROSCOPY; MELTING POINT; MODEL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; POLYMERIZATION; POROSITY; SCANNING ELECTRON MICROSCOPY; SOLID; STRUCTURE ANALYSIS; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TEMPERATURE DEPENDENCE; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

ACRYLIC RESINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HEAT; INDOMETHACIN; POLYMERS; POROSITY; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TABLETS; TIME FACTORS;

EID: 27744440375     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.07.009     Document Type: Article

References (27)

1. H.F. Mark, N. Bikales, and J.I. Kroschwitz Anionic Polymerization to Cationic Polymerization 1985 Encyclopedia of Polymer Science and Engineering Willey, New York (Vol. 2)
2. L. Nielson Mechanical Properties of Polymers and Composites 1974 Marcel Dekker New York
3. M.R. Harris, L. Ghebre-Sellassie, and R.U. Nesbitt A water-based coating process for sustained release Pharm. Tech. 10 1986 102 107
4. I. Ghebre-Sellassie, U. Iyer, D. Kubert, and M.B. Fawzi Characterization of a new water-based coating for modified-release preparations Pharm. Tech. 12 1988 96 106
5. S. Porter The use of Opadry, Coateric and Surelease in the aqueous film coating of pharmaceutical oral dosage forms J.W. McGinity Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms 1989 Marcel Dekker New York 317 362
6. B.H. Lippold, B.K. Sutter, and B.C. Lippold Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersions Int. J. Pharm. 54 1989 15 25
7. T. Wheatly Applications of Aquacoat ethylcellulose aqueous dispersions for sustained release Y. Kaseshima Recent Advances on Aqueous Polymeric Coating System and Related Techniques, Proceedings of the Pre World Congress, Particle Technology 1990 Gifu Japan 11 17 (Sept.)
8. S. Milojevic, J.M. Newton, J.H. Cummings, G.R. Gibson, R.L. Botham, S.G. Ring, M. Stockham, and M.C. Allwood Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets J. Control. Release 38 1996 75 84
9. H. Sugao, S. Yamazaki, H. Shiozawa, and K. Yano Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles J. Pharm. Sci. 87 1998 96 100
10. M.O. Omelczuk, and J.W. McGinity The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly (dl-lactic acid) Pharm. Res. 10 1993 542 548
11. N. Billa, K. Yuen, and K. Peh Diclofenac release from Eudragit-containing matrices and effects of thermal treatment Drug Dev. Ind. Pharm. 24 1998 45 50
12. T. Maejima, and W. McGinity Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers Pharm. Dev. Technol. 5 2001 211 221
13. S. Azarmi, J. Farid, A. Nokhodchi, S.M. Bahari-Saravi, and H. Valizadeh Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices Int. J. Pharm. 246 2002 171 177
14. R. Bodmeier, and O. Paeratakul Process and formulation variables affecting the drug release from chlorpheniramine maleate-loaded beads coated with commercial and self-prepared aqueous ethyl cellulose pseudolatexes Int. J. Pharm. 70 1991 59 68
15. E.S. Ghali, G.H. Klinger, and J.B. Schwartz Thermal Treatment of Beads with Wax for Controlled Release 1989 1311 1328 (15)
16. M. Otsuka, F. Kato, and Y. Matsuda Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry Analyst 126 2001 1578 1582
17. M. Kidokoro, N.H. Shah, A.W. Malick, M.H. Infeld, and J.W. McGinity Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes Pharm. Dev. Technol. 6 2001 263 275
18. H.M. Abdou Dissolution, Bioavailability and Bioequivalence, Mack 1989 Easton
19. K.J. Crowley, and G. Zografi Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formulation and amorphous phase physical stability J. Pharm. Sci. 91 2002 492 507
20. S.Y. Lin, and R.I. Perng Solid-state interaction studies of drugs/polymers, part 1. Indomethacin/Eudragit E, RL or S resins S.T.P. Pharma Sci. 3 1993 465 471
21. S.Y. Lin Isolation and solid-state characteristics of a new crystal form of indomethacin J. Pharm. Sci. 81 1992 572 576
22. S.Y. Lin, Y.Y. Lin, and C.L. Cheng Studies on the compatibility, efficiency and permanence of plasticizers on drug-free or drug-loaded Eudragit E films Pharmazie 50 1995 801 805
23. M.A. Khan, A.A. Karnachi, V. Agarwal, S.R. Vaithiyalingam, S. Nazzal, and I.K. Reddy Stability characterization of controlled release coprecipitates and solid dispersions J. Control. Release 63 2000 1 6
24. L. Borka Polymorphism of indomethacin. New modifications, their melting behavior and solubility Acta Pharm. Suecica 11 1974 295 303
25. H. Imaizumi, N. Nambu, and T. Nagai Stability and several physical properties of amorphous and crystalline forms of indomethacin Chem. Pharm. Bull. (Tokyo) 28 1980 2565 2569
26. N. Kaneniwa, M. Otsuka, and T. Hayashi Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol Chem. Pharm. Bull. (Tokyo) 33 1985 3447 3455
27. K. Terada, H. Kitano, Y. Yoshihashi, and E. Yonemochi Quantitative correlation between the initial dissolution rate and the heat of the solution of the drug Pharm. Res. 17 2000 920 924